Results 111 to 120 of about 68,714 (218)

Novel approaches to treating advanced systemic mastocytosis

Clinical Pharmacology: Advances and Applications, 2019
JA Gilreath,1 L Tchertanov,2 MW Deininger31Department of Pharmacotherapy, College of Pharmacy and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; 2Centre de Mathématiques et de Leurs Applications (CMLA-CNRS), ENS ...
Gilreath JA, Tchertanov L, Deininger MW
doaj  

Critical care management of systemic mastocytosis: when every wasp is a killer bee [PDF]

, 2015

core   +1 more source

Clonal Mast Cell Disorders and Mutation Profile in Adults Initially Presenting with Mast Cell Activation (Anaphylaxis) versus Non-Anaphylactic Presentations: A Joint Allergy-Hematology Cohort. [PDF]

J Asthma Allergy
Pornsuthirat P, Owattanapanich W, Wongsa C, Thongngarm T, Sompornrattanaphan M.   +4 more
europepmc   +1 more source

Commentary: Think anaphylaxis [PDF]

, 2009
Daele, P.L.A. (Paul) van
core   +3 more sources

Reconsidering cytoreductive therapy in high-risk pediatric mastocytosis: From diffuse cutaneous to smoldering systemic disease. [PDF]

J Allergy Clin Immunol Glob
Giavina-Bianchi M, de Paula Santos MF, Jacob AT, Miranda SA, Kalil J, Giavina-Bianchi P.   +5 more
europepmc   +1 more source

Management Strategy for Anaphylaxis in a Patient With Suspected or Confirmed Mastocytosis: A Case Report. [PDF]

Am J Case Rep
Smoluchowski K, Szymański M, Skiba MM, Piasecka M.   +3 more
europepmc   +1 more source

Aggressive Systemic Mastocytosis Presenting as Diffuse Osteoblastic Bone Disease: A Diagnostic Pitfall Mimicking Metastatic Cancer. [PDF]

Eur J Case Rep Intern Med
Melício A, Gonçalves HD, Dias M, Vasconcelos-Teixeira S, Madeira Lopes J.   +4 more
europepmc   +1 more source

Hereditary Alpha-Tryptasemia and Mastocytosis: What We Know and What We Need To Learn. [PDF]

Curr Allergy Asthma Rep
Rama TA, Gulen T.
europepmc   +1 more source

Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis. [PDF]

World Allergy Organ J
Pongdee T, Castells M, Akin C, Dybedal I, Gotlib J, Panse JP, Alvarez-Twose I, Cabeza CM, Cerquozzi S, Vadas P, Swarup V, Vachhani P, Wortmann F, Yi CA, Bidollari I, Newberry K, Shaheen D, Hartmann K.   +17 more
europepmc   +1 more source

Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis. [PDF]

Cureus
Minbaeva S, Tyring SK.
europepmc   +1 more source